Statement of Clinical Relevance
- •We report a case of ONJ with pembrolizumab, a rare yet possibly emerging complication. The number of patients using pembrolizumab will likely continue to increase. We document this instance to better inform dental treatment around cancer patients undergoing pembrolizumab therapy.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'